Advertisement

Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies

Cariad Chester, Miguel F. Sanmamed, Jun Wang and Ignacio Melero

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted June 14, 2017
  • Accepted September 6, 2017
  • Published online November 8, 2017.


Contributors 
  • Cariad Chester, 1 Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, United States;
  • Miguel F. Sanmamed, 2 Department of Immunobiology, Yale University School of Medicine, New Haven, CT, United States;
  • Jun Wang, 2 Department of Immunobiology, Yale University School of Medicine, New Haven, CT, United States;
  • Ignacio Melero, 3 Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output